ReviewAdvances in neurobiology2023
Nanodelivery of Histamine H3/H4 Receptor Modulators BF-2649 and Clobenpropit with Antibodies to Amyloid Beta Peptide in Combination with Alpha Synuclein Reduces Brain Pathology in Parkinson's Disease.
Anca D Buzoianu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.